COMMUNIQUÉS West-GlobeNewswire

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
04/12/2024
IRVINE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI™ assay. In a paper recently [...]
Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Modulate Tumor Immunity
04/12/2024
Data published in peer-reviewed npj Drug Discovery, a Nature portfolio journal BURLINGAME, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical [...]
Prenetics Announces Participation in December Investor Conferences
04/12/2024
CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team [...]
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
04/12/2024
BANNOCKBURN, Ill., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will [...]
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting
04/12/2024
RNS System to be featured in over 70 scientific presentations and posters Pre-book a demonstration in the NeuroPace Tech Suite to see the latest innovations of the RNS System which simplify the treatment experience for [...]
Acutus Medical Announces Operational Downsizing
04/12/2024
CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and operational downsizing. Dr. Shaden Marzouk, Chairperson [...]
Spineway carries out a capital reduction by reducing the par value of its shares
04/12/2024
Press release Ecully, December 4, 2024 – 8 p.m. CET Spineway carries out a capital reduction by reducing the par value of its shares The Spineway Group, a specialist in innovative implants for the treatment of severe [...]
SPINEWAY procède à une réduction de capital social par diminution de la valeur nominale de l’action
04/12/2024
Communiqué de presse Ecully, le 4 décembre 2024 – 20h Spineway procède à une réduction de capital social par diminution de la valeur nominale de l’action Le groupe Spineway, spécialiste des implants innovants pour le [...]
Milestone Scientific to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
04/12/2024
ROSELAND, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that [...]
Safe Group - Distribution contract signed with Wenzel
04/12/2024
Distribution contract signed with Wenzel Fleurieux-sur-l’Arbresle - France – December 4, 2024 at 6 p.m. Safe SA (la « Société ») announces the signing of strategic agreements between Safe Orthopaedics, a pioneer in [...]
SAFE GROUP - Contrat de distribution signé avec Wenzel
04/12/2024
Contrat de distribution signé avec Wenzel Fleurieux-sur-l’Arbresle - France - le 4 décembre 2024 à 18h . Safe SA (la « Société ») annonce la signature de contrats stratégiques entre les sociétés Safe Orthopaedics, [...]
OSE Immunotherapeutics : Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant le Capital
04/12/2024
Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant le Capital Nantes, le 4 décembre 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
Corza Medical se classe au 14e rang parmi les 100 plus grandes entreprises de technologies de la santé en 2024
04/12/2024
WESTWOOD, Mass., 04 déc. 2024 (GLOBE NEWSWIRE) -- Corza Medical (« Corza » ou la « Société »), une entreprise de technologie médicale de premier rang à l’échelle mondiale, s’engageant à proposer des services [...]
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery
04/12/2024
VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and clinical efficacy compared to vehicle in treating post-operative inflammation following cataract surgery [...]
Oxford Treatment Center Expands to Southaven, Bringing Quality Addiction Treatment to the Greater Memphis Area
04/12/2024
SOUTHAVEN, Miss., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Oxford Treatment Center celebrated the opening of its new outpatient facility in Southaven with a ribbon-cutting ceremony on December 3rd. This ceremony marks a [...]
Sonnet BioTherapeutics Announces Publication Detailing the Discovery and Development of SON-1010, an Albumin-Binding IL-12 Fusion Protein, Demonstrating Its Mechanism of Action
04/12/2024
Pankaj Mohan, CEO of Sonnet discusses what this publication means in a Virtual Investor “What This Means” segment; access here PRINCETON, NJ, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the [...]
Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer
04/12/2024
HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatments Positive study results are expected to drive further adoption of Focal One [...]
OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial with Vivo, a Novel genAI Clinical Trial Control Tower
04/12/2024
Vivo Empowers Clinical Development Teams to Accelerate Decision-making and Analyses in Clinical Trials for Improved Outcomes HOUSTON and BOCA RATON, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- OmniScience and INmune Bio ( [...]
Dror Ortho-Design Posts Updated CEO Investor Presentation
04/12/2024
JERUSALEM, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's [...]

Pages